Lipitor U.S. Sales Tank 70% in 2012 vs 2011!

According to Drugs.com, Lipitor U.S. sales in Q2 of 2012 were only 30% of what they were in Q2 2011 ($579 million vs. $1,949 million, respectively (see chart below; Source: http://www.drugs.com/stats/lipitor).


Meanwhile, sales of Crestor (a competitor anti-cholesterol drug) increased only somewhat during the same period (see chart below; Source: http://www.drugs.com/stats/crestor).


I conclude that most of the loss of Lipitor sales was due to direct competition from generic versions of Lipitor now currently available, which is further proof that Pfizer's "innovative" attempts to stem the generic Lipitor tide has failed (see also "Pfizer Throws In the Lipitor Marketing Towel").

3 comments:

Dose Pharmacy said...

Such delightful.
to get Online pharmacy from Dose Pharmacy

unknown said...

I really found this to much informatics.It is good to see you verbalize from the heart and clarity on this important subject can be easily observed...

dresses for girls

John Hardy said...

I got a very intersting information in this article about sales of tank. Hope in future you more good updates. Now it's time to avail car service boynton beach fl for more information.

Post a Comment